Contrasting Roles of NADPH Oxidase Isoforms in Pressure-Overload Versus Angiotensin II–Induced Cardiac Hypertrophy
Data up to Jan 2025
Total Citations Per Year
Abstract
References (12)
NAD(P)H Oxidase
2000 • 2,902 citations
NADPH Oxidase: An Update
1999 • 2,134 citations
Role of oxidative stress in cardiovascular diseases
2000 • 1,429 citations
Novel gp91 phox Homologues in Vascular Smooth Muscle Cells
2001 • 841 citations
Pivotal Role of a gp91 phox -Containing NADPH Oxidase in Angiotensin II-Induced Cardiac Hypertrophy in Mice
2002 • 524 citations
Inhibitory Effects of Antioxidants on Neonatal Rat Cardiac Myocyte Hypertrophy Induced by Tumor Necrosis Factor-α and Angiotensin II
1998 • 509 citations
A Novel Superoxide-producing NAD(P)H Oxidase in Kidney
2001 • 508 citations
Activation of NADPH Oxidase During Progression of Cardiac Hypertrophy to Failure
2002 • 507 citations
Reactive Oxygen Species Mediate Amplitude-Dependent Hypertrophic and Apoptotic Responses to Mechanical Stretch in Cardiac Myocytes
2001 • 332 citations
Role of reactive oxygen species and NAD(P)H oxidase in α1-adrenoceptor signaling in adult rat cardiac myocytes
2002 • 297 citations
Redox‐sensitve intermediates mediate angiotensin II‐induced p38 MAP kinase activation, AP‐1 binding activity, and TGF‐β expression in adult ventricular cardiomyocytes
2001 • 154 citations
The antioxidant N-2-mercaptopropionyl glycine attenuates left ventricular hypertrophy in in vivo murine pressure-overload model
2002 • 148 citations